Filtered By:
Infectious Disease: HIV AIDS
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 1364 results found since Jan 2013.
Atopic Dermatitis Polypharmacy and Out-Of-Pocket Healthcare Expenses
CONCLUSION: Individuals with AD report considerable polypharmacy, which is associated with increased OOP expenses and harmful financial impact. Strategies are needed to reduce polypharmacy, minimize OOP costs, and optimize clinical outcomes. J Drugs Dermatol. 2023;22(2): doi:10.36849/JDD.7038.PMID:36745366 | DOI:10.36849/JDD.7038
Source: Journal of Drugs in Dermatology - February 6, 2023 Category: Dermatology Authors: Raj Chovatiya Wendy Smith Begolka Isabelle Thibau Jonathan Silverberg Source Type: research
Chronic viral coinfections differentially affect the likelihood of developing long COVID
CONCLUSION Overall, these findings suggest differential effects of chronic viral coinfections on the likelihood of developing LC and association with distinct syndromic patterns. Further assessment during the acute phase of COVID-19 is warranted.TRIAL REGISTRATION Long-term Impact of Infection with Novel Coronavirus; ClinicalTrials.gov NCT04362150.FUNDING This work was supported by NIH/National Institute of Allergy and Infectious Diseases grants (3R01AI141003-03S1, R01AI158013, and K24AI145806); the Zuckerberg San Francisco General Hospital Department of Medicine and Division of HIV, Infectious Diseases, and Global Medicin...
Source: Journal of Clinical Investigation - February 2, 2023 Category: Biomedical Science Authors: Michael J. Peluso, Tyler-Marie Deveau, Sadie E. Munter, Dylan Ryder, Amanda Buck, Gabriele Beck-Engeser, Fay Chan, Scott Lu, Sarah A. Goldberg, Rebecca Hoh, Viva Tai, Leonel Torres, Nikita S. Iyer, Monika Deswal, Lynn H. Ngo, Melissa Buitrago, Antonio Rod Source Type: research
Preexposure Prophylaxis Gives Good Results in Latin America Preexposure Prophylaxis Gives Good Results in Latin America
A prospective Brazilian study found that same-day initiation of PrEP for HIV prevention is feasible and is associated with high adherence and long-term engagement.Medscape Medical News
Source: Medscape Allergy Headlines - January 20, 2023 Category: Allergy & Immunology Tags: HIV/AIDS News Source Type: news
Janssen and Global Partners to Discontinue Phase 3 Mosaico HIV Vaccine Clinical Trial
LEIDEN, THE NETHERLANDS, (January 18, 2023) – The Janssen Pharmaceutical Companies of Johnson & Johnson, together with a consortium of global partners, today announced the results of an independent, scheduled data review of the Phase 3 Mosaico study (also known as HPX3002/HVTN706) of Janssen’s investigational HIV vaccine regimen. The study’s independent Data and Safety Monitoring Board (DSMB) determined that the regimen was not effective in preventing HIV infection compared to placebo among study participants. No safety issues with the vaccine regimen were identified.In light of the DSMB’s determination, the Mo...
Source: Johnson and Johnson - January 18, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study
Lancet HIV. 2023 Jan 12:S2352-3018(22)00365-4. doi: 10.1016/S2352-3018(22)00365-4. Online ahead of print.ABSTRACTBACKGROUND: Long-acting injectable cabotegravir pre-exposure prophylaxis (PrEP) is recommended by WHO as an additional option for HIV prevention in sub-Saharan Africa, but there is concern that its introduction could lead to an increase in integrase-inhibitor resistance undermining treatment programmes that rely on dolutegravir. We aimed to project the health benefits and risks of cabotegravir-PrEP introduction in settings in sub-Saharan Africa.METHODS: With HIV Synthesis, an individual-based HIV model, we simul...
Source: Cancer Control - January 15, 2023 Category: Cancer & Oncology Authors: Jennifer Smith Loveleen Bansi-Matharu Valentina Cambiano Dobromir Dimitrov Anna Bershteyn David van de Vijver Katharine Kripke Paul Revill Marie-Claude Boily Gesine Meyer-Rath Isaac Taramusi Jens D Lundgren Joep J van Oosterhout Daniel Kuritzkes Robin Sch Source Type: research
Late Diagnosis of HIV: An Updated Consensus Definition Late Diagnosis of HIV: An Updated Consensus Definition
A consensus panel provides an update to the definition of late HIV diagnosis.HIV Medicine
Source: Medscape Allergy Headlines - January 6, 2023 Category: Allergy & Immunology Tags: HIV/AIDS Journal Article Source Type: news
